Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.
The item "Receivables-Turnover" stands at 4.62 as of 09/30/2025, the lowest value since 03/31/2024.
As of the end of Sumitomo Dainippon Pharma Co Ltd's second quarter, the item "Receivables Turnover" stands at 4.62. This represents a decrease of -9.22 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -17.45 percent compared to the value the year prior.
The 1 year change in percent is -17.45.
The 3 year change in percent is -69.38.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Receivables Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Receivables Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Receivables Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Receivables Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Receivables Turnover | 280,205,508,085.11 |